Akashi D, Issa FK, Pereira AC, Tannuri AC, Fucciolo DQ, Lobato ML, Galvão TG, Benseñor IM, Lotufo PA. [Antihypertensive treatment. Prescription and cost of drugs. Survey in a tertiary care hospital].
Arq Bras Cardiol 1998;
71:55-7. [PMID:
9755535 DOI:
10.1590/s0066-782x1998000700010]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
PURPOSE
To study the most prescribed anti-hypertensive drugs, evaluating their agreement with established guidelines and drug cost.
METHODS
One hundred and forty one (101 women, mean age = 53.3 years) hypertensive patients who searched spontaneous attention were interviewed in a tertiary-care hospital. The inclusion criteria were previous diagnosis of hypertension and non cardiovascular complaints.
RESULTS
The majority of the 107 (75.9%) patients were on medical treatment. In those receiving monotherapy, thiazides were the most utilized drugs, followed by methyldopa, ACE inhibitors, calcium channel-blockers, and beta-blockers. The association with thiazides (26.3%) followed the same preference. The second most prescribed drug, methyldopa, was the more expensive. Fifty percent of the patients purchased the drugs at their own expense.
CONCLUSION
A preference for prescription of expensive drugs for hypertension was detected in this sample in Brazil. This does not agree with major guidelines, mainly the V-JNC, which suggest thiazides and betablockers as first choice drugs for hypertensives with no complications or associated comorbidity.
Collapse